Lymphoma Perspectives

Patient Education

Patient Perspectives: Understanding Diagnostic Testing

Lymphoma specialist Lisa Rimsza, MD (Mayo Clinic, Arizona) describes these tests in-depth and how they can help patients understand their lymphoma subtype and become their own best health advocate.

Mobile Health Technology Helps Blood Cancer Patients Navigate Diagnosis

These days, a cellphone is much more than just a phone – it’s a photo album, a GPS, a stereo system, an encyclopedia, a computer, a gaming system, a suite of tools all in the palm of your hand. One of the many tools that can be accessed via mobile technology are apps intended to help manage your health, sometimes known as mobile health technology.

lymphoma

Patient Perspectives: Advocating for Adolescents and Young Adults

On June 23rd and 24th, 2022, physicians and scientists from more than 40 academic and medical institutions, federal agencies, and pharmaceutical companies were brought together in Jersey City, New Jersey for the second Lymphoma Research Foundation’s (LRF) Adolescent and Young Adult (AYA) Lymphoma Consortium Scientific Workshop.

lymphoma

What Lymphoma Patients Need to Know About Current Treatments for COVID-19

As of mid-2022, there are a number of treatments for COVID-19 that have been either approved by the FDA or have been authorized for emergency use (EUA).

lymphoma

Patient Perspectives: Dispelling Myths About Clinical Trials

Clinical trials are important for advancing research and can provide patients with access to the most cutting-edge treatments. LRF Associate Director of Support Services and Helpline specialist, Izumi Nakano, answers some common questions about clinical trials to help better understand the process and what to think about when considering enrolling in one.

lymphoma

U.S. Food and Drug Administration Approves Rituximab (RITUXAN) Plus Chemotherapy for Pediatric B-cell Lymphomas

Rituximab (RITUXAN, Genentech, Inc.), a monoclonal antibody, has been approved in combination with chemotherapy for pediatric patients 6-18 months with previously untreated, advanced staged, CD20-positive diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), and Burkitt-like lymphoma (BLL).

lymphoma

COVID-19 Vaccine Updates and FAQs

The Lymphoma Research Foundation (LRF) encourages patients, survivors, and their care partners to take information and questions back to their individual health care providers as a way of creating a dialogue and partnership about their lymphoma and treatment.

lymphoma, Mantle Cell Lymphoma

Hope Forever and a Day

For more than 23 years, Marla Briskman faced her lymphoma—enduring five relapses and six different treatments. What gave her hope? Incredible treatment advancements and the support of family, friends, and her husband and care partner, Rickey.

lymphoma

Care Partner Perspectives: Managing The Responsibilities of Caring for a Loved One

A lymphoma diagnosis not only affects the patient, but their care partners too. LRF Scientific Advisory Board member, Thomas M. Habermann, MD shares some helpful strategies on how to help cope with some of the pressures of being a care partner.

lymphoma

Three Healthy Ways to Navigate the Internet While Coping with a Lymphoma Diagnosis

Here are some ways lymphoma patients, survivors and caregivers can best navigate the internet for information, emotional and social support needs.

Subscribe to Our Emails. Get lymphoma and CLL resources and updates.